Cargando…
Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat
INTRODUCTION: It has been well documented that the pineal hormone, melatonin, which plays a major role in the control of reproduction in mammals, also plays a role in the incidence and growth of breast and mammary cancer. The curative effect of melatonin on the growth of dimethylbenz [a]anthracene-i...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175060/ https://www.ncbi.nlm.nih.gov/pubmed/15987452 http://dx.doi.org/10.1186/bcr1031 |
_version_ | 1782124501845147648 |
---|---|
author | Lenoir, Véronique Yon de Jonage-Canonico, Marianne Beau Perrin, Marie-Hélène Martin, Antoine Scholler, Robert Kerdelhué, Bernard |
author_facet | Lenoir, Véronique Yon de Jonage-Canonico, Marianne Beau Perrin, Marie-Hélène Martin, Antoine Scholler, Robert Kerdelhué, Bernard |
author_sort | Lenoir, Véronique |
collection | PubMed |
description | INTRODUCTION: It has been well documented that the pineal hormone, melatonin, which plays a major role in the control of reproduction in mammals, also plays a role in the incidence and growth of breast and mammary cancer. The curative effect of melatonin on the growth of dimethylbenz [a]anthracene-induced (DMBA-induced) mammary adenocarcinoma (ADK) has been previously well documented in the female Sprague–Dawley rat. However, the preventive effect of melatonin in limiting the frequency of cancer initiation has not been well documented. METHODS: The aim of this study was to compare the potency of melatonin to limit the frequency of mammary cancer initiation with its potency to inhibit tumor progression once initiation, at 55 days of age, was achieved. The present study compared the effect of preventive treatment with melatonin (10 mg/kg daily) administered for only 15 days before the administration of DMBA with the effect of long-term (6-month) curative treatment with the same dose of melatonin starting the day after DMBA administration. The rats were followed up for a year after the administration of the DMBA. RESULTS: The results clearly showed almost identical preventive and curative effects of melatonin on the growth of DMBA-induced mammary ADK. Many hypotheses have been proposed to explain the inhibitory effects of melatonin. However, the mechanisms responsible for its strong preventive effect are still a matter of debate. At least, it can be envisaged that the artificial amplification of the intensity of the circadian rhythm of melatonin could markedly reduce the DNA damage provoked by DMBA and therefore the frequency of cancer initiation. CONCLUSION: In view of the present results, obtained in the female Sprague–Dawley rat, it can be envisaged that the long-term inhibition of mammary ADK promotion by a brief, preventive treatment with melatonin could also reduce the risk of breast cancer induced in women by unidentified environmental factors. |
format | Text |
id | pubmed-1175060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-11750602005-07-14 Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat Lenoir, Véronique Yon de Jonage-Canonico, Marianne Beau Perrin, Marie-Hélène Martin, Antoine Scholler, Robert Kerdelhué, Bernard Breast Cancer Res Research Article INTRODUCTION: It has been well documented that the pineal hormone, melatonin, which plays a major role in the control of reproduction in mammals, also plays a role in the incidence and growth of breast and mammary cancer. The curative effect of melatonin on the growth of dimethylbenz [a]anthracene-induced (DMBA-induced) mammary adenocarcinoma (ADK) has been previously well documented in the female Sprague–Dawley rat. However, the preventive effect of melatonin in limiting the frequency of cancer initiation has not been well documented. METHODS: The aim of this study was to compare the potency of melatonin to limit the frequency of mammary cancer initiation with its potency to inhibit tumor progression once initiation, at 55 days of age, was achieved. The present study compared the effect of preventive treatment with melatonin (10 mg/kg daily) administered for only 15 days before the administration of DMBA with the effect of long-term (6-month) curative treatment with the same dose of melatonin starting the day after DMBA administration. The rats were followed up for a year after the administration of the DMBA. RESULTS: The results clearly showed almost identical preventive and curative effects of melatonin on the growth of DMBA-induced mammary ADK. Many hypotheses have been proposed to explain the inhibitory effects of melatonin. However, the mechanisms responsible for its strong preventive effect are still a matter of debate. At least, it can be envisaged that the artificial amplification of the intensity of the circadian rhythm of melatonin could markedly reduce the DNA damage provoked by DMBA and therefore the frequency of cancer initiation. CONCLUSION: In view of the present results, obtained in the female Sprague–Dawley rat, it can be envisaged that the long-term inhibition of mammary ADK promotion by a brief, preventive treatment with melatonin could also reduce the risk of breast cancer induced in women by unidentified environmental factors. BioMed Central 2005 2005-04-29 /pmc/articles/PMC1175060/ /pubmed/15987452 http://dx.doi.org/10.1186/bcr1031 Text en Copyright © 2005 Lenoir et al.; licensee BioMed Central Ltd. |
spellingShingle | Research Article Lenoir, Véronique Yon de Jonage-Canonico, Marianne Beau Perrin, Marie-Hélène Martin, Antoine Scholler, Robert Kerdelhué, Bernard Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title | Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title_full | Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title_fullStr | Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title_full_unstemmed | Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title_short | Preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female Sprague–Dawley rat |
title_sort | preventive and curative effect of melatonin on mammary carcinogenesis induced by dimethylbenz[a]anthracene in the female sprague–dawley rat |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175060/ https://www.ncbi.nlm.nih.gov/pubmed/15987452 http://dx.doi.org/10.1186/bcr1031 |
work_keys_str_mv | AT lenoirveronique preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat AT yondejonagecanonicomariannebeau preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat AT perrinmariehelene preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat AT martinantoine preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat AT schollerrobert preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat AT kerdelhuebernard preventiveandcurativeeffectofmelatoninonmammarycarcinogenesisinducedbydimethylbenzaanthraceneinthefemalespraguedawleyrat |